Asenapine Sublingual Tablets bulk supplier for pharma manufacturers

Asenapine Sublingual Tablets 5 mg, 10 mg Suppliers & Bulk Manufacturers

Available Forms: Sublingual Tablets

Available Strengths: 5 mg, 10 mg

Reference Brands: Saphris®(US); Sycrest® (EU)

Asenapine blocks dopamine D2 and serotonin 5-HT2A receptors, helping manage symptoms of schizophrenia and bipolar I disorder. Its sublingual delivery allows rapid absorption, making it effective for acute manic or mixed episodes, especially in patients needing fast symptom relief or with difficulty swallowing oral tablets.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Asenapine sublingual tablets are FDA-approved in the U.S. for treating schizophrenia and bipolar I disorder (acute manic or mixed episodes) in adults and pediatric patients. In the EU, they are approved under national procedures for similar indications. Regulatory compliance requires GMP-certified manufacturing, validated sublingual bioavailability data, and robust clinical safety profiles addressing risks such as oral numbness, extrapyramidal symptoms, and metabolic effects. U.S. regulations mandate boxed warnings for elderly patients with dementia-related psychosis. EU approval includes Risk Management Plans (RMPs) and pharmacovigilance systems. For dossier-ready Asenapine sublingual tablets, visit Pharmatradz.com — your B2B pharma sourcing expert.

Asenapine Sublingual Tablets — third party manufacturing & bulk supply

Asenapine Sublingual Tablets 5 mg, 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Asenapine Sublingual Tablets is supplied as Sublingual Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Asenapine Sublingual Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Asenapine Sublingual Tablets →

Back to Listing

Frequently Asked Questions

Asenapine Sublingual Tablets is listed as Sublingual Tablets in 5 mg, 10 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Asenapine Sublingual Tablets is referenced against Saphris®(US); Sycrest® (EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.